Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431136
Max Phase: Preclinical
Molecular Formula: C26H25FN4O2
Molecular Weight: 444.51
Molecule Type: Small molecule
Associated Items:
ID: ALA2431136
Max Phase: Preclinical
Molecular Formula: C26H25FN4O2
Molecular Weight: 444.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2nc(-c3ccccc3)nc(N3CCN(c4ccc(F)cc4)CC3)c2cc1OC
Standard InChI: InChI=1S/C26H25FN4O2/c1-32-23-16-21-22(17-24(23)33-2)28-25(18-6-4-3-5-7-18)29-26(21)31-14-12-30(13-15-31)20-10-8-19(27)9-11-20/h3-11,16-17H,12-15H2,1-2H3
Standard InChI Key: QJSSVXHQDQGEIJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 444.51 | Molecular Weight (Monoisotopic): 444.1962 | AlogP: 4.78 | #Rotatable Bonds: 5 |
Polar Surface Area: 50.72 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.50 | CX LogP: 6.19 | CX LogD: 6.19 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.44 | Np Likeness Score: -1.34 |
1. Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Li Y, Milewski M, Gosalia P, Gray W, Mehta A, Sugarman E, Hood B, Suyama E, Nguyen K, Heynen-Genel S, Vasile S, Salaniwal S, Stonich D, Su Y, Mangravita-Novo A, Vicchiarelli M, Roth GP, Smith LH, Chung TD, Hanson GR, Thomas JB, Caron MG, Barak LS, Pinkerton AB.. (2013) Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor., 4 (9): [PMID:24611085] [10.1021/ml400176n] |
Source(1):